NUCP-001

N/A

Report date: 2025/01/26 16:09:23

NME

Base Information

Drug NameNUCP-001

Drug Alias Namecell penetrating nanocarrier (Nuclixbio)NUCP-001

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer

Mechanisms of ActionApoptosis stimulants

TargetsUpdating

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNuclixBio Inc

China Registration ClassN/A

Active CompaniesNuclixBio Inc

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A